WIP
PFE icon

Wellesley Investment Partners’s Pfizer PFE Stock Holding History

Wellesley Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$900K Sell
25,862
-2,356
-8% -$82.6K 0.31% 31
2020
Q2 		$875K Sell
28,218
-3,663
-11% -$124K 0.31% 33
2020
Q1 		$987K Sell
31,881
-1,163
-4% -$39.6K 0.39% 26
2019
Q4 		$1.23M Buy
33,044
+194
+0.6% +$6.91K 0.38% 28
2019
Q3 		$1.12M Buy
32,850
+4,123
+14% +$150K 0.37% 25
2019
Q2 		$1.18M Sell
28,727
-6,935
-19% -$275K 0.41% 26
2019
Q1 		$1.44M Buy
35,662
+92
+0.3% +$3.68K 0.49% 27
2018
Q4 		$1.47M Sell
35,570
-1,879
-5% -$78K 0.52% 25
2018
Q3 		$1.56M Buy
37,449
+1,416
+4% +$54.5K 0.51% 27
2018
Q2 		$1.24M Buy
36,033
+884
+3% +$30.2K 0.43% 38
2018
Q1 		$1.18M Buy
35,149
+1,493
+4% +$51.3K 0.43% 37
2017
Q4 		$1.16M Buy
33,656
+2,297
+7% +$78.3K 0.44% 39
2017
Q3 		$1.06M Buy
31,359
+349
+1% +$11.2K 0.44% 36
2017
Q2 		$988K Buy
31,010
+830
+3% +$26.2K 0.42% 43
2017
Q1 		$979K Buy
30,180
+2,427
+9% +$76.5K 0.43% 40
2016
Q4 		$855K Buy
27,753
+4,579
+20% +$140K 0.41% 41
2016
Q3 		$744K Sell
23,174
-927
-4% -$31K 0.39% 43
2016
Q2 		$805K Sell
24,101
-251
-1% -$8.01K 0.43% 28
2016
Q1 		$685K Buy
24,352
+3,742
+18% +$107K 0.41% 37
2015
Q4 		$631K Buy
+20,610
New +$648K 0.43% 34

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellesley Investment Partners's PFE Position: Q3 2020 in Review

Wellesley Investment Partners reduced its Pfizer (PFE) stake by 8.3% in Q3 2020, selling an estimated $82.6K and leaving 25,862 shares worth $900K. The position accounts for 0.31% of the portfolio, ranked #31.

Wellesley Investment Partners first reported a position in PFE in Q4 2015 and has held it in 20 quarters since. The position peaked at $1.56M in Q3 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • Wellesley Investment Partners held 25,862 shares of Pfizer worth $900K as of Q3 2020.
  • Wellesley Investment Partners sold 2,356 Pfizer shares in Q3 2020, an estimated $82.6K.
  • Pfizer made up 0.31% of Wellesley Investment Partners's portfolio in Q3 2020, its #31 holding.
  • Wellesley Investment Partners first reported a position in Pfizer in Q4 2015 and has held it in 20 quarters since.
  • Wellesley Investment Partners's Pfizer position peaked at $1.56M in Q3 2018.
  • 2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Wellesley Investment Partners's 13F filing for Q3 2020, filed 30 Oct 2020.